Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure. The Italian Microalbuminuria Study Group in IDDM

Diabetes Care
G CrepaldiR Nosadini

Abstract

Intervention trials on renal function in IDDM patients with microalbuminuria (MA) should adopt the rate of decline of glomerular filtration rate (GFR) as an outcome measure. However, normotensive IDDM patients with MA show no change in GFR over a follow-up period of 10 years. Thus, in the present study, we used the cumulative incidence of progression to albuminuria (albumin excretion rate [AER] > 200 micrograms/min) from MA as the primary endpoint and the yearly increase in AER at a rate of 50% above baseline as the secondary end-point of renal function. Ninety-two normotensive IDDM patients underwent double-blind, double-dummy treatment with either lisinopril or slow-release nifedipine in comparison with placebo. Ten patients discontinued the study during the 3-year follow-up period. During the 3-year follow-up period, 7 of 34 placebo-treated (20.6%), 2 of 32 lisinopril-treated (6.3%), and 2 of 26 nifedipine-treated (7.7%) patients progressed to clinical albuminuria (Fisher's exact test, P < 0.03). Time-to-event analysis indicated a reduction in the risk of progression to macroalbuminuria of 58.1% (95% CI 27.8-68.4%) in the 32 patients on lisinopril (P < 0.02) and of 62.5% (95% CI 32.5-73.4%) in the 26 patients on nifedipine (...Continue Reading

Citations

Apr 11, 2000·The Journal of Maternal-fetal Medicine·G Leguizamon, E A Reece
Apr 4, 2008·Diabetologia·K J SchjoedtH-H Parving
Dec 1, 2005·Current Diabetes Reports·Bruce A Perkins, Andrzej S Krolewski
Sep 2, 2003·Current Hypertension Reports·Douglas A Nigbor, Julia B Lewis
May 28, 2004·Diabetes Research and Clinical Practice·Brad A SobolewskiTrevor J Orchard
Dec 28, 2002·Clinical Therapeutics·Eva M Vivian, Gail Breen Rubinstein
Nov 2, 2001·Diabetes Research and Clinical Practice·S Baba, UNKNOWN J-MIND Study Group
Dec 1, 2001·Endocrinology and Metabolism Clinics of North America·J S Skyler
Nov 13, 2001·Kidney International·H H Parving
Nov 5, 1999·The New England Journal of Medicine·D R Abernethy, J B Schwartz
Mar 5, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ausilia MaioneGiovanni F M Strippoli
Feb 22, 2002·Current Opinion in Nephrology and Hypertension·Karin Jandeleit-Dahm, Mark E Cooper
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·P L Chan, N H Holford
Jan 23, 1999·Clinical Chemistry and Laboratory Medicine : CCLM·R Mangili
Nov 13, 2013·Clinical and Experimental Nephrology·Andrzej S KrolewskiMonika A Niewczas
Sep 12, 2000·Current Hypertension Reports·A A Taylor, S Sunthornyothin
Oct 16, 2004·Current Cardiology Reports·Mitra K NadimVito M Campese
Dec 5, 2009·Clinical and Experimental Nephrology·UNKNOWN Japanese Society of Nephrology
Jul 28, 1999·Clinical and Experimental Hypertension : CHE·C E Mogensen
Aug 24, 2000·BJOG : an International Journal of Obstetrics and Gynaecology·B SzekacsE A Brinton
Nov 26, 2015·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Xinfang XieHaiyan Wang
Jul 23, 2003·Diabetic Medicine : a Journal of the British Diabetic Association·R E GilbertD J Kelly
Jan 7, 2004·Diabetic Medicine : a Journal of the British Diabetic Association·C E Mogensen, M E Cooper
Apr 4, 2003·Diabetes/metabolism Research and Reviews·Giacomo DeferrariValeria Berruti
Jun 26, 2003·Journal of Internal Medicine·C E Mogensen
Jan 30, 2004·Internal Medicine Journal·D W Johnson
Oct 6, 2007·The Journal of Clinical Hypertension·Panagiotis C StafylasAnastasios N Lasaridis
Apr 7, 2004·Acta Clinica Belgica·A DerwaR Vanholder
Jan 30, 2002·Diabetes Care·Han-Henrik ParvingCarl Erik Mogensen
Jul 15, 2016·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Nicolás R RoblesGuido Grassi
Apr 15, 2003·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Per Løstrup Poulsen
Mar 7, 2002·Journal of the Renin-angiotensin-aldosterone System : JRAAS·C E Mogensen
Jul 5, 2018·British Journal of Clinical Pharmacology·Seyyed-Reza Sadat-EbrahimiAmir Azarpazhooh
Jun 7, 2005·Journal of the American Society of Nephrology : JASN·Maura RaveraGiacomo Deferrari
Jun 7, 2005·Journal of the American Society of Nephrology : JASN·Michael J KrimholtzGiancarlo Viberti
May 16, 2000·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·B Nielsen, A Flyvbjerg
Apr 17, 2001·The Annals of Pharmacotherapy·E M Vivian, M L Goebig
Feb 28, 2021·Kidney International·UNKNOWN Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group
Oct 2, 2020·Kidney International·UNKNOWN Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group
Dec 6, 2002·Journal of the American Society of Nephrology : JASN·Giacomo DeferrariDenise Parodi

❮ Previous
Next ❯

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.